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THE RELATIONSHIP BETWEEN HIP IMPAIRMENTS AND CHRONIC
LOW BACK PAIN IN OLDER ADULTS: A PRELIMINARY STUDY
G.E. Hicks, J.M. Sions, T. Velasco. Univ. of Delaware, Newark, DE, USA
Purpose: Among older adults, low back pain (LBP) is the most
frequently reported musculoskeletal problem. From a clinical perspective,
rehabilitation professionals have often noted a link between hip
dysfunction and LBP among older adults. Ofﬁerski and McNab originally
described hip-spine syndrome as the presence of symptoms due to an
abnormal biomechanical relationship between the hip joint and spine
likely related to degenerative pathology in one or both joints; but, little
work has been done to elucidate this relationship. The purpose of this
study was to preliminarily assess whether clinical hip impairments,
which are indicative of hip osteoarthritis (OA), were associated with the
presence of chronic LBP among older adults.
Methods: We have conducted a preliminary comparative study of
community-dwelling older adults with and without chronic LBP,
including 82 participants (mean age: 71.53±6.57 years) of whom 43
had CLP and 42 were pain-free. Participants were included if they were
between 60 and 85 years old and had not experienced recent trauma,
spinal surgery or recent treatment for LBP. Participants with chronic LBP
were included if (1) he/she had experienced LBP on most days for at
least the past three months, (2) reported pain severity >3 on the Pain
Thermometer, and (3) reported no other bodily pain greater than their
LBP. Individuals in the control group were included if they had no current
LBP and had not had any LBP for the previous six months. We examined
clinical hip impairments that were proposed predictors of radiographic
hip OA according to American College of Rheumatology (ACR) guidelines,
including hip joint pain, morning stiffness in the hip that lasts /=15
degrees. Participants were also asked to self-report whether they had
been given a radiographic diagnosis of hip OA by a physician. Chi-
square analysis was used to determine differences in the prevalence of
hip impairments between older adults with and without chronic LBP.
A series of logistic regression models were also ﬁt with LBP group as
the response variable and the clinical hip impairment variables from the
ACR clinical prediction rules as the criterion variables. Logistic regression
models were adjusted for age, sex and race.
Results: Hip joint pain (37.2% vs. 11.9%, p = 0.01), morning stiffness (30.2%
vs. 11.9%, p = 0.06) and pain with hip IR (16.3% vs. 2.4%, p = 0.03) were
more common among older adults with chronic LBP. In fact, 53.5% of all
participants with chronic LBP had at least one hip symptom as compared
to only 16.7% of the pain-free group (p < 0.0001). The presence of at least
one clinical hip symptom (joint pain, pain with IR or morning stiffness)
was signiﬁcantly associated with more than a 7-fold greater odds of
having chronic LBP [OR (95% CI): 7.15 (2.30–22.21)]. Individually, hip
internal rotation ROM was not signiﬁcantly associated with CLBP status
(p > 0.05). For each additional clinical hip impairment present (including
symptom and ROM variables), there was more than a 2-fold increase in
the odds of having chronic LBP [OR (95% CI): 2.20 (1.17–4.12)]. Finally,
14% of the participants with LBP reported a radiographic diagnosis of hip
OA compared to 2.4% of the group without LBP (p =0.06).
Conclusions: Clinical hip impairments are more prevalent among older
adults with chronic LBP as compared to their peers without pain. There
has long been consensus that researchers should focus on classifying
patients into clinically relevant subgroups that share similar clinical
characteristics to improve treatment outcomes. It appears that one such
subgroup among older adults with chronic LBP consists of those with
co-existing hip impairments. Our preliminary data suggests that the
relationship between LBP and co-existing hip impairments should be
systematically studied in order to determine if hip joint dysfunction
should be a potential treatment target for some older adults with
chronic LBP.
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INCIDENCE AND RISK FACTORS FOR RADIOGRAPHIC LUMBAR
SPONDYLOSIS: THE ROAD STUDY
S. Muraki1, T. Akune1, H. Oka1, K. Nakamura2, H. Kawaguchi2,
N. Yoshimura1. 122nd Century Med. and Researh Ctr., The Univ. of Tokyo,
Tokyo, Japan; 2Sensory and Motor System Med., The Univ. of Tokyo, Tokyo,
Japan
Purpose: To examine the incidence of radiographic lumbar spondylosis
and lower back pain, and their risk factors using a large-scale population-
based cohort in Japan.
Methods: Subjects from the ROAD cohort, a population-based cohort
for the prospective study of musculoskeletal diseases including
osteoarthritis, who had been recruited in 2005–2007 were followed
up with lumbar spine radiography 3 years later. A total of 2,282
paired radiographs (75% of the original sample) were graded for
Kellgren Lawrence (KL) grade, and the incidence and progression rate
of radiographic lumbar spondylosis was examined. The incident rate
of lower back pain was also examined. Risk factors were tested for
their association with incident and progressive radiographic lumbar
spondylosis and incident lower back pain.
Results: The mean age of 2,282 subjects (758 men, 1,524 women)
at follow-up was 72.1±11.5 years. Given the 3.3-year follow-up, the
incident rate of KL ≥ 2 radiographic lumbar spondylosis was 50.0 and
34.6% (15.3 and 10.5% per year), while that of KL ≥ 3 lumbar spondylosis
was 15.3 and 23.8% (4.6 and 7.2% per year), in men and women. The
progression rate of lumbar spondylosis was 20.5 and 27.3% (6.2 and
8.3% per year) and the incident rate of lower back pain was 28.3 and
31.2% (8.6% and 9.5% per year) in men and women. Multiple logistic
regression analysis showed that age was a risk factor for incidence of
KL ≥2 and KL ≥3 lumbar spondylosis (+1 year, odds ratio (OR) 1.05,
95% conﬁdence interval (CI) 1.03–1.06, and OR 1.06, 95% CI 1.04–1.07,
respectively). Higher body mass index (BMI) was also a risk factor for
KL ≥2 lumbar spondylosis (+1 kg/m2, OR 1.07, 95% CI 1.02–1.13), but not
for KL ≥3 lumbar spondylosis. Grip strength was not associated with the
incidence of KL ≥2 or KL ≥3 lumbar spondylosis. Female gender was a
protective factor against the incidence of KL ≥2 lumbar spondylosis (vs.
men, OR 0.50, 95% CI 0.34–0.72), but was a risk factor for the incidence of
KL ≥3 lumbar spondylosis (vs. men, OR 2.50, 95% CI 1.60–3.92). KL grade
at baseline was signiﬁcantly associated with the incidence of KL ≥3
lumbar spondylosis. Lower back pain at baseline was not associated
with incident KL ≥2 or KL ≥3 lumbar spondylosis. We further examined
the number of KL ≥3 vertebral interspaces among L2/3, 3/4, 4/5 and
5/S interspaces. Multiple logistic regression analysis after adjustment for
age showed that the OR (95% CI) for having 1, 2 or 3 or more KL ≥3
vertebral interspaces for incident lower back pain was 1.27 (0.89–1.80),
1.46 (0.95–2.22) and 1.81 (1.29–2.54), respectively, in women. A logistic
regression analysis showed that there were no association between 1 and
2 KL ≥3 vertebral interspaces with incident lower back pain and no KL ≥3
vertebral interspaces in men, but that 3 KL ≥3 vertebral interspaces had
signiﬁcant association with incident lower back pain (OR 1.69, 95% CI
1.03–2.75). Lower back pain at baseline was not signiﬁcantly associated
with incident radiographic lumbar spondylosis, while a severer KL grade
at baseline was associated with incident lower back pain.
Conclusions: The present longitudinal study revealed a high incidence
of radiographic lumbar spondylosis in Japan. Higher BMI was a risk
factor for incident KL ≥2 lumbar spondylosis, but not for KL ≥3 lumbar
spondylosis, progressive lumbar spondylosis. Female gender was a
protective factor for incidence of KL ≥2 lumbar spondylosis, but was
a risk factor for incidence of KL ≥3 lumbar spondylosis, suggesting that
different mechanisms might inﬂuence the initiation and/or progression
of osteophytosis and disc space narrowing. Further progress, along with
continued longitudinal surveys of the ROAD study, will elucidate the
environmental and genetic backgrounds of lumbar spondylosis.
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CELL VIABILITY IN HUMAN SAMPLES OF HERNIATED
INTERVERTEBRAL DISC: IMPLICATIONS FOR BIOLOGICAL THERAPIES
S.A. Turner1, W.E. Johnson2, J. Trivedi3, S. Roberts1. 1Robert Jones & Agnes
Hunt Orthopaedic Hosp. & ISTM Keele Univ., Oswestry, United Kingdom;
2Aston Univ., Birmingham, United Kingdom; 3Robert Jones & Agnes Hunt
Orthopaedic Hosp., Oswestry, United Kingdom
Purpose: The intervertebral disc is dependent on the extracellular matrix
for its function, which is produced and maintained by the resident cells.
However, disc degeneration is common and may present early on in life,
being associated with major clinical problems such as herniation and
back pain. Previous work suggests that cells isolated from the degenerate
intervertebral disc have a very limited potential for regeneration, with
a number of the cells necrotic and/or senescent. Never-the-less cells
are currently being used in the clinic for cell therapy which have been
isolated from routine discectomy patients. Since regulatory authorities
are now placing more emphasis on cell therapies being classed as
pharmaceutical products, a deeper knowledge of the source and quality
of cells used is required. Thus, this study was designed to assess the
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viability of cells present in surgical samples of degenerate intervertebral
disc tissue.
Methods: The technique for live/dead differentiation of cells used in this
study utilises the ﬂuorescent probes chloromethyl ﬂuorescein diacetate
(CMFDA) and ethidium homodimer (EH). Samples of herniated discs were
obtained from patients undergoing routine discectomy and processed
within 2 hours of excision. A small piece of each sample, approximately
5mm2, was incubated in 1ml of 25mM CMFDA/2mM EH solution in the
dark for 2 hours at 37°C. The tissue was then blotted dry and snap frozen.
Cryosections were taken at various points throughout the thickness of the
tissue sample, mounted with Vectashield containing DAPI and visualised
with a ﬂuorescent microscope. Cell viability was analysed by counting
at least 200 cells from a minimum of ﬁve ﬁelds of view.
Results: To date 21 surgical disc samples from patients, aged 17–57 years,
have been examined. Preliminary results show that greater than 80%
of cells are alive after excision. Cells in these discs commonly occur
in clusters (approximately 54% of disc cells are clustered). Clustered
cells exhibited a higher proportion of live cells compared to single cells
within the same tissue section, e.g. 93% of clustered cells were viable
compared to 82% of single cells. Cell viability appeared consistent across
all locations of the disc samples. Dead cells, when they did occur, were
predominantly seen around the periphery of the disc sections which
may be derived from trauma during dissection.
Conclusions: In contrast to reports in the literature, these results indicate
that the viability of cells from the herniated disc may be adequate
to consider for utilising in biological therapies. Interestingly, a greater
proportion of clustered cells appear to be viable compared to single cells.
Additionally we plan to investigate whether there is any relationship
between cell viability and the pathology, duration of symptoms or age of
patient, as this may serve as an indicator of the suitability of degenerate
discs for cell therapy.
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INTRADISCAL INJECTIONS OF ORTHOKINE-DERIVED AUTOLOGOUS
CONDITIONED SERUM (ACS) FOR LUMBAR DISC DEGENERATION
C. Moser1, D.D. Groenemeyer1, J. Becker1, J. Hartmann2, P. Wehling2.
1Groenemeyer Insitute for Microtherapy, Bochum, Germany; 2Private Group
Practice Professor Wehling, Dr. Hartmann, Duesseldorf, Germany
Purpose: Biology offers several strategies for restoring the degenerating
disc, including the use of natural proteins that increase matrix
accumulation and assembly, enhance the number of disc cells, or in other
ways lead to restoration of the native healthy disc. This is the basis for
administering Orthokine-derived Autologous Conditioned Serum (ACS) a
new treatment method that not only supplies with a pharmaceutical
monosubstance but with nutrients, anti-inﬂammatory cytokines and
several growth factors.
When peripheral blood is withdrawn and incubated with etched glass
beads, leukocytes within the aspirate enrich the plasma with anti-
inﬂammatory cytokines, such as IL-1Ra, as well as growth factors,
including PDGF, FGF-2, TGFb, IGF and HGF. After centrifuging and ﬁltering,
the ACS is returned locally to the affected region. It has been used
successfully, by way of local injection, for the treatment of human and
equine osteoarthritis, after ACL-reconstructive surgery and radiculopathy
(see references).
Methods: A non-blinded, prospective study was conducted to evaluate
feasibility and efﬁcacy of ACS injections in patients suffering from lumbar
disc pain (veriﬁed by anamnesis and clinics, MRI scan and distension
tests, no relieve after 8 weeks of well conducted conservative treatment,
pain reduction less than 50% VAS, after periradicular inﬁltration
procedures). 19 patients had a discography and three intradiscal
injections of ACS once per week for three consecutive weeks and were
followed for six months. Outcome was measured by patient administered
outcome instruments (VAS, ODI).
Results: Patients with showed a clinically remarkable and signiﬁcant
reduction in pain and disability after the ACS injection series. Mean
improvement was 58% in VAS. 11 out of 19 patients reported at least
50% pain improvement. No serious side effects occurred. There were no
infections in this series.
Conclusions: Although, these results must be conﬁrmed in larger clinical
trails and with objective assessments like quantitative MRI scans, the use
of ACS in the intervertebral disc could be worthy of consideration given
its impressive safety record and rich mixture of growth factors, cytokine
antagonists, and, possibly, additional helpful agents.
Fig. 1. ACS Production 1.1–1.5. For the ACS preparation whole blood
is drawn using special syringes (Orthokine EOT Syringe, Orthogen,
Duesseldorf, Germany) with increased inner surface area (1). While
the blood is incubated for six to nine hours (2), peripheral blood
leukocytes reproducibly produce elevated amounts of endogenous anti-
inﬂammatory cytokines. Following centrifugation and extraction (3+4),
autologous conditioned cell free serum (ACS) is then portioned (5) and
either stored until needed at minus 18° Celsius or directly injected into
the affected disc, joint or spinal region of the patient.
Table 1. Cytokines and growth factors present in autologous conditioned
serum (ACS) produced using the 10ml Orthokine system.
Mean
IL-1Ra 2015 pg
IL-6 28.7 pg
IL-10 33.4 pg
FGF b 27 pg
VEGF 509 pg
HGF 1,339 pg
IGF1 117,209 pg
PDGG AB 39,026 ng
TFG b 97,939 ng
Abbr.: IL-1Ra = interleukin-1 receptor antagonist; IL-6 = interleukin-6;
IL-10 = interleukin-10; FGFb = ﬁbroblast growth factor-b; VEGF = vascular
endothelial growth factor, HGF = hepatocyte growth factor; IGF1= insulin-
likegrowth-factor-1; PDGF = platelet derived growth factor, TGF-b =
transforming growth-factor-b. There is no noticeable induction of the
proinﬂammatory IL-1b or TNF-a. Measurements from ELISA kits (R&D
Systems).
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MESENCHYMAL STEM CELLS IN TYPE I COLLAGEN VEHICLES AS
AN ADDITIONAL TREATMENT FOR ROTATOR CUFF TEARS: A RAT
EXPERIMENTAL MODEL
P. Tornero-Esteban, C. Rodriguez-Bobada, J. Hoyas, E. Villafuertes,
F. Marco, B. Fernandez-Gutierrez. Hosp. Clinico San Carlos, Madrid, Spain
Introduction: Supraspinatus tendon (SE) is an essential structure for
the proper function of rotator cuff and it is the most frequently tendon
affected in the case of rotator cuff tears. Common surgical procedures
to repair SE lesions are often unsatisfactory due to the inadequate
recovery. Regenerative medicine is one of the most promising techniques
to improve these treatments by taking advantage of the regenerative
potential of mesenchymal stem cells (MSCs).
The aim of this study was to evaluate, in an experimental rat model, the
effectiveness of recovery after surgical treatment using MSCs embedded
in collagen type I vehicles.
Methodology: A chronic rotator cuff tear model was developed detaching
at the insertion site the SE of adult Sprague-Dawley rats (9 months old),
n = 4.
One month post-injury, the tendon was sutured with a type I collagen
vehicle with or without MSCs. One million cells, previously obtained
from the femoral channel of age matched rats were embedded in type I
collagen gel (n = 4) or attached to type I collagen membranes (n =4). In
parallel, a control group was treated only with the vehicle type I collagen
gel (n = 4) or with type I collagen membrane (n =4), free of cells.
Recovery was evaluated for each specimen three months after injury
determining the biomechanical strength (Newtons, N) of the tendon-
humerus interface (Instron). The contralateral shoulder was used as a
